Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000614177 | SCV000711265 | benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | Glu1649Asp in Exon 36 of PCDH15: This variant is not expected to have clinical s ignificance because it has been identified in 1.5% (35/2374) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs16937768). |
Labcorp Genetics |
RCV000965805 | SCV001113082 | benign | not provided | 2021-04-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000965805 | SCV001778047 | likely benign | not provided | 2018-09-28 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000614177 | SCV001924042 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000614177 | SCV001970629 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004530735 | SCV004751122 | benign | PCDH15-related disorder | 2019-07-12 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |